节点文献
基于lnc RNA H19/miR-22/Wnt通路探索补肾强督方干预人骨髓间充质干细胞成骨分化的作用机制
Exploration on the mechanism of Bushen Qiangdu Formula intervention on osteogenic differentiation of human bone marrow mesenchymal stem cells based on the lncRNA H19/miR-22/Wnt pathway
【摘要】 目的:研究补肾强督方对人骨髓间充质干细胞(hBMSCs)成骨分化的影响及其作用机制。方法:用补肾强督方含药血清处理hBMSCs,诱导成骨分化14 d,茜素红染色评估矿化程度,RT-PCR检测成骨细胞标志物及H19、miR-22的表达,Western Blot检测β-catenin和DKK-1的表达。构建H19过表达的hBMSCs,并加入补肾强督方高剂量含药血清干预,诱导成骨分化14 d后再次检测上述指标。结果:与空白对照组比较,补肾强督方含药血清抑制hBMSCs成骨分化,补肾强督方高剂量组可降低Wnt通路中的β-catenin表达(P<0.01),上调DKK-1的表达(P<0.01),并降低H19的表达(P<0.05),增加miR-22的表达(P<0.01)。与H19过表达组比较,补肾强督方高剂量含药血清能部分挽救H19过表达引起的hBMSCs成骨分化(P<0.01,P<0.05),调节DKK-1和β-catenin的表达(P<0.01,P<0.05)。结论:补肾强督方可能通过lncRNA H19/miR-22/Wnt通路干预hBMSCs的成骨分化,为该方在AS病理性成骨中的应用提供了理论依据。
【Abstract】 Objective: To investigate the effects and mechanisms of Bushen Qiangdu Formula(BSQD) on the osteogenic differentiation of human bone marrow mesenchymal stem cells(hBMSCs). Methods: hBMSCs were treated with BSQDcontaining serum to induce osteogenic differentiation for 14 d. Alizarin Red staining was performed to evaluate the degree of mineralization. RT-PCR was used to detect osteogenic cell markers, as well as the expression of H19 and miR-22. Western Blot was conducted to examine the expression of β-catenin and DKK-1. hBMSCs with overexpression of H19 were constructed,and high-dose BSQD-containing serum was added to intervene. After inducing osteogenic differentiation for 14 d, the abovementioned indicators were re-evaluated. Results: Compared with control group, BSQD-containing serum could inhibit the osteogenic differentiation of hBMSC, high-dose BSQD-containing serum could reduce the expression of β-catenin in the Wnt pathway(P<0.01), upregulate the expression of DDK-1(P<0.01), and decrease the expression of H19(P<0.05) while increasing the expression of miR-22(P<0.01). Compared with H19 overexpression group, high-dose BSQD-containing serum could partially rescue the osteogenesis caused by H19 overexpression in hBMSCs(P<0.01, P<0.05), regulate the expression of DKK-1 and β-catenin(P<0.01, P<0.05). Conclusion: BSQD may intervene in the bone formation and differentiation of hBMSCs through the lncRNA H19/miR-22/Wnt pathway, providing a theoretical basis for the application of BSQD in pathological osteogenesis.
【Key words】 Bushen Qiangdu Formula; Human bone marrow mesenchymal stem cells(hBMSCs); Osteogenic; Ankylosing spondylitis(AS);
- 【文献出处】 中华中医药杂志 ,China Journal of Traditional Chinese Medicine and Pharmacy , 编辑部邮箱 ,2025年01期
- 【分类号】R285
- 【下载频次】60